Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

84 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Therapeutic Virtual Reality : Impact on the Management of Pain and Anxiety Related to Hematology Care (REVEH)

NCT03483194

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • SOL Clinique Sainte-Anne Strasbourg, Alsace, France
  • Institut Bergonié Bordeaux, Gironde, France
  • CHU Angers Angers, Pays de Loire, France
  • Centre Jean Bernard - Clinique Victor Hugo Le Mans, France
View Trial Details
Completed

Platelet Transfusion Requirements in Hematopoietic Transplantation Pilot Study

NCT02650791

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Hamilton Health Sciences - Juravinski Hospital and Cancer Centre Hamilton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • The Ottawa Hospital Ottawa, Ontario, Canada
View Trial Details
Completed

Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator

NCT01802879

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • City of Hope National Medical Center Dept.ofCityofHopeMedicalCtr(1) Duarte, California, United States
  • Georgia Regents University SC-2 Augusta, Georgia, United States
  • Dana Farber Cancer Institute Reg. Ped Boston, Massachusetts, United States
  • University of Utah / Huntsman Cancer Institute SC-2 Salt Lake City, Utah, United States
View Trial Details
Completed

Phase I Trial of BAY1251152 for Advanced Blood Cancers

NCT02745743

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • New York, United States
  • The Bronx, New York, United States
  • Nashville, Tennessee, United States
  • Dresden, Saxony, Germany
View Trial Details
Completed

Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancer

NCT00900614

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • Section of Haematology and Coagulation, Sahlgrenska University Hospital Gothenburg, Sweden
  • Department of Hematology, University Hospital Örebro, Sweden
  • Urology clinic, University Hospital Örebro, Sweden
  • Hematology Centre, M54, Karolinska Institute, Karolinska University Hospital, Huddinge Stockholm, Sweden
View Trial Details
Completed

Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units

NCT02504047

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • Foothills Medical Center / Tom Baker Cancer Center Calgary, Alberta, Canada
  • Health Sciences Center Winnipeg, Manitoba, Canada
  • Ottawa General Hospital Ottawa, Ontario, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details

Related conditions